Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 Mg Per 2 ML, 2 ML Fill in a 2 ML Vial Due to Out-Of-Specification Endotoxin Results in Certain Reserve Samples
November 08, 2025
November 08, 2025
WASHINGTON, Nov. 8 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following recall notice:
* * *
Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of-Specification Endotoxin Results in Certain Reserve Samples
Summary
Company Announcement Date: November 06, 2025
FDA Publish Date: . . .
* * *
Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of-Specification Endotoxin Results in Certain Reserve Samples
Summary
Company Announcement Date: November 06, 2025
FDA Publish Date: . . .